For The Better

The average benefit varies widely by age, and research shows some filing ages are better than others.

Annaly Capital has a huge 13% dividend yield, but don’t buy it for the yield because the stock may end up letting you down in the long run.

These are two of healthcare’s biggest darlings right now, but one looks better positioned for the long run.

Each of these could be a millionaire-maker, and together they could be part of a supercharged growth portfolio.

It isn’t easy to be positive on the struggling company’s prospects.

Pfizer’s high dividend yield and robust pipeline could offer significant returns for patient investors.

The electric vehicle maker’s stock has been on the decline following the reveal of its self-driving robotaxi and humanoid robot Optimus.

Regulators are coming after Visa’s dominant role in the payments industry.

Bitcoin hit all-time highs earlier this year before paring some of those gains.

Enterprise Products Partners is one of the highest-quality, high-yielding dividend stocks.

These companies are rewarding their shareholders with dividends and capital gains.

Artificial intelligence is spreading through the corporate sector like wildfire.

It’s an option worth looking into, but it may not be ideal for you.

These two companies are very similar, but they operate in different regions.

Third-quarter results exceeded estimates, but the company also lowered overall earnings expectations for 2024.

Here are two issues investors need to consider before buying the dip.

Buy now and thank yourself later.

Your Social Security benefit will be reduced, but in some cases it can still make sense to start collecting benefits early.

Shares of Meta Platforms, Spotify, and Netflix are trading at hefty prices.

Palantir’s business has changed a lot since 2021, but has the stock?